| Heinemann, V.; Ebert, M. P.; Laubender, Rüdiger P.; Bevan, P.; Mala, C.; Boeck, S. (2013): Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer. In: British Journal of Cancer BJC, Vol. 108, No. 4: pp. 766-770 |
Full text not available from 'Open Access LMU'.
DOI: 10.1038/bjc.2013.62
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine > Institute for Medical Information Processing, Biometry and Epidemiology |
| Subjects: | 600 Technology > 610 Medicine and health |
| ISSN: | 0007-0920 |
| Language: | English |
| ID Code: | 33246 |
| Deposited On: | 15. Feb 2017 14:43 |
| Last Modified: | 04. Nov 2020 13:10 |
Repository Staff Only: item control page
